Association analysis of formyl peptide receptor 2 (FPR2) polymorphisms and Aspirin exacerbated respiratory diseases

Authors:
  • SCSung-Hwan Cho
    Sung-Hwan Cho
  • JPJong-Sook Park
    Jong-Sook Park
  • TLTae-Hyeong Lee
    Tae-Hyeong Lee
  • ELEun-Ju Lee
    Eun-Ju Lee
  • YKYong-Hoon Kim
    Yong-Hoon Kim
  • SUSoo-Taek Uh
    Soo-Taek Uh
  • ICIl Yup Chung
    Il Yup Chung
  • MKMi-Kyeong Kim
    Mi-Kyeong Kim
  • ICInseon S Choi
    Inseon S Choi
  • BPByung-Lae Park
    Byung-Lae Park
  • HSHyoung-Doo Shin
    Hyoung-Doo Shin

Abstract
Aspirin-exacerbated respiratory diseases (AERD) are associated with the metabolism of arachidonic acid. FPR2 (formyl peptide receptor2) is a high-affinity ligand receptor for potent anti-inflammatory lipid metabolites: lipoxins. Thus, functional alterations of the FPR2 may contribute to AERD. We investigated the relationship between single-nucleotide polymorphisms (SNPs) in the FPR2 and AERD. Asthmatics were categorized into AERD G (rs1769490) in intron 2 was significantly lower in the AERD group (n=170) than in the ATA group (n=268) (P=0.006, P(corr)=0.04, recessive model). The decline of FEV(1) after aspirin challenge was significantly lower in the subjects with GG homozygotes of FPR2 -4209T>G than those with the other genotypes (P=0.0002). Asthmatic homozygotes for FPR2 -4209T>G minor allele exhibited significantly higher FPR2 protein expression in CD14-positive monocytes than did those with the common allele of FPR2 -4209T>G allele (P=0.01). There was no difference in the expression of the wild form and the exon 2 deleted variant form of FPR2 gene according to the genotypes of FPR2 -4209T>G. The minor allele at FPR2 -4209T>G may have a protective role against the development of AERD, via increase of FPR2 protein expression in inflammatory cells.

This publication has 34 references indexed in Scilit: